Skip to main content

Table 2 The changes in the phospholipid levels in the PFC and hippocampus following LPS and Pl injection

From: Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice

  Con LPS LPS + Pls Pls
1) PFC     
PlsEtn 16.40 ± 0.59 13.41 ± 0.73* 16.29 ± 0.53 17.81 ± 0.32
PEtn 21.92 ± 0.63 22.66 ± 0.65 22.48 ± 0.26 22.65 ± 0.22
PlsCho 0.20 ± 0.03 0.19 ± 0.03 0.21 ± 0.03 0.28 ± 0.04
PCho 44.04 ± 1.12 47.73 ± 1.04 43.73 ± 0.97 46.74 ± 0.85
SM 3.72 ± 0.20 3.13 ± 0.31 3.47 ± 0.24 3.31 ± 0.15
PS 11.88 ± 0.27 11.08 ± 0.30 12.03 ± 0.22 10.58 ± 0.56
PI 1.86 ± 0.12 1.80 ± 0.07 1.87 ± 0.21 1.64 ± 0.31
PlsEtn/PEtn ratio 0.75 ± 0.02 0.59 ± 0.03* 0.73 ± 0.03 0.79 ± 0.01
2) Hippocampus     
PlsEtn 24.18 ± 0.64 20.29 ± 0.31* 22.88 ± 0.45 22.68 ± 0.39
PEtn 20.38 ± 0.43 22.07 ± 0.62 20.21 ± 0.41 20.80 ± 0.57
PlsCho 0.49 ± 0.06 0.42 ± 0.04 0.45 ± 0.05 0.41 ± 0.03
PCho 36.90 ± 1.74 39.39 ± 0.38 37.64 ± 1.37 39.90 ± 1.04
SM 5.24 ± 0.67 5.36 ± 0.59 5.71 ± 0.64 4.13 ± 0.68
PS 11.73 ± 0.86 10.94 ± 0.25 11.71 ± 0.61 10.59 ± 0.34
PI 1.59 ± 0.10 1.63 ± 0.16 1.72 ± 0.06 1.48 ± 0.16
PlsEtn/PEtn ratio 1.19 ± 0.05 0.92 ± 0.03* 1.14 ± 0.04 1.09 ± 0.05
  1. The values are expressed as the mean ± SEM (n = 5) of the % level of the phospholipids, except for the last row. *, P <0.05 compared to the Con group (Steel test for multiple comparisons). Con, control; PCho, phosphatidyl choline; PEtn, phosphatidyl ethanolamine; PFS, prefrontal cortex; LPS, lipopolysaccharide; PI, phosphatidyl inositol; Pl, plasmalogen; PlsCho, choline plasmalogen; PlsEtn, ethanolamine plasmalogen; PS, phosphatidyl serine; SEM, standard error of the mean; SM, sphingomyelin.